A study on COVID-19 vaccine effectiveness, finding it 55% effective against hospitalizations and 50% against emergency visits, was published in JAMA Network Open after being blocked from a CDC journal. Political appointees cited design flaws, while researchers defended the "test-negative design" as reliable.
A new study from a US Department of Veterans Affairs health system found that updated COVID-19 vaccines offer significant protection against cardiovascular disease, particularly for individuals over 75 and those with pre-existing conditions. The vaccines reduced the risk of major adverse cardiovascular events (MACE) by 38%.
FDA has suppressed studies on COVID-19 vaccines and Shingrix, a shingles vaccine.
A Belgian court has ruled that Poland and Romania must fulfill their EU contract obligations and purchase €1.9 billion worth of COVID-19 vaccines from Pfizer and BioNTech, rejecting arguments that declining infection rates justified non-compliance.
